| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000035273 |
| Receipt No. | R000040176 |
| Official scientific title of the study | Prospective observational study of blood flow alterations in response to provocation tests and progression in ophthalmic disorders including glaucoma |
| Date of disclosure of the study information | 2018/12/16 |
| Last modified on | 2018/12/16 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Prospective observational study of blood flow alterations in response to provocation tests and progression in ophthalmic disorders including glaucoma | |
| Title of the study (Brief title) | Blood flow alterations in response to provocation tests in ophthalmic disorders | |
| Region |
|
|
| Condition | ||
| Condition | Glacuoma, cataract, dry eye, diabetic retinopathy, retinal vein occlusion, hypertensive retinopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We prospectively investigate the relationship between blood flow alterations in response to provocation tests and visual field progression in glaucoma patients. In addition, we investigate the blood flow alterations in response to provocation tests in ophthalmic disorders, including diabetic retinopathy, retinal vein occlusion, hypertensive retinopathy, cataract and dry eye patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relationship between ocular blood flow alterations in response to provocation tests and glaucoma progression. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Open angle
2. From preperimetric to moderate glaucoma stages 3. Reliable results of visual filed test 4, Obtain for informed consent |
|||
| Key exclusion criteria | 1. High myopia
2. Intraocular pressure above 22mmHg in both eyes 3. Allergy for topical medications 4. Pregnancy 5. Current smoker 6. History of uncomfortable for provocation tests 7. Impossible to assess ocular blood flow because of severe cataract 8. Presence of ocular fundus disorders other than diabetic retinopathy and retinal vein occlusion 9. Impossible to obtain informed consent |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Kunikata |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Ophthalmology |
| Address | 1-1, Seiryo-cho, Aoba-ku, Sendai-shi |
| TEL | 0227177294 |
| kunikata@oph.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Yukihiro Shiga |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Ophthalmology |
| Address | 1-1, Seiryo-cho, Aoba-ku, Sendai-shi |
| TEL | 0227177294 |
| Homepage URL | |
| y.shiga@oph.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology, Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding and Center of Innovation Program |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040176 |